Unilever reports double-digit turnover growth in first half of 2012
3 August 2012 16:15 in Consumer Healthcare News
Unilever has reported further strong growth in the face of a challenging market during the first six months of 2012.
The company's turnover for the half-year came to 25.4 billion euros (20.09 billion pounds), up by 11.5 percent year on year, while underlying sales growth was measured at seven percent.
Its strong performance in emerging markets helped to make up for the slowdown seen in developed regions, with the rollout of key brands in new markets proving instrumental in this.
In terms of personal care products, product lines such as Dove, Axe and Vaseline were all highlighted as positive performers.
Paul Polman, chief executive officer of Unilever, said: "Our performance reflects continued investment in innovation, brand-building and people, whilst keeping discipline on both costs and execution."
This week also saw the company agree the sale of its North American frozen meals business to ConAgra Foods, allowing it to focus on other core areas.
Other news stories from 03/08/2012
Read more in the Zenopa News Archive
How this news is generated
Story collated for Zenopa by the Adfero News Agency